Showing 561–580 of 650 signals
Trade press·medpagetoday.com·Aug 17, 2026·Commercial·High materiality
CompaniesChildren's Hospital ColoradoUniversity of Maryland Medical SystemAssetssemaglutideexenatideDiseasespolyendocrine metabolic ovarian syndrome
Trade press·medpagetoday.com·Aug 17, 2026·Other·High materiality
CompaniesNextstrainFred Hutch Cancer Center
Trade press·medpagetoday.com·Aug 17, 2026·Other·High materiality
Diseaseshepatitis Ahepatitis B
Trade press·medpagetoday.com·Aug 17, 2026·Other·Low materiality
Diseasesfetus-in-fetu
Trade press·medpagetoday.com·Aug 17, 2026·Discontinuation·Low materiality
CompaniesStallergenes GreerAssetsPalforziaDiseasespeanut allergy
Trade press·medpagetoday.com·Aug 17, 2026·Other·High materiality
DiseasesCOVID-19
Trade press·medpagetoday.com·Aug 17, 2026·Other·Low materiality
Diseasesosteoarthritis
Trade press·medpagetoday.com·Aug 17, 2026·Other·High materiality
DiseasesEbola
Trade press·medpagetoday.com·Aug 17, 2026·Other·High materiality
Diseasesacute gastroenteritisrotavirus infection
Trade press·medpagetoday.com·Aug 17, 2026·Commercial·High materiality
Diseasesinfluenza
Trade press·medpagetoday.com·Aug 17, 2026·Other·High materiality
Trade press·medpagetoday.com·Aug 17, 2026·Other·High materiality
Diseasesmeaslesmumpsrubellapoliodiphtheriatetanuspertussischickenpoxhepatitis B
Trade press·pharmatimes.com·Aug 10, 2026·Trial readout·High materiality
CompaniesObsidian TherapeuticsAssetsamsoki-celDiseasesadvanced melanoma
Trade press·pharmatimes.com·Aug 10, 2026·Approval·High materiality
CompaniesAstraZenecaAssetsacalabrutinibvenetoclaxbendamustinerituximabDiseaseschronic lymphocytic leukaemiamantle cell lymphoma
Trade press·pharmatimes.com·Aug 11, 2026·Other·Low materiality
Trade press·pharmatimes.com·Aug 11, 2026·Approval·High materiality
CompaniesLexeo TherapeuticsAssetsLX2020DiseasesPKP2 arrhythmogenic cardiomyopathy
Trade press·pharmatimes.com·Aug 12, 2026·Trial readout·High materiality
CompaniesStablepharmaAssetsSPVX02
Trade press·pharmatimes.com·Aug 12, 2026·Approval·High materiality
CompaniesChiesi UK and IrelandAssetsdelayed-release mercaptamine bitartrateDiseasesnephropathic cystinosis
Trade press·pharmatimes.com·Aug 13, 2026·Approval·High materiality
CompaniesALKAssetsACARIZAX (12 SQ-HDM SLIT)Diseaseshouse dust mite allergic rhinitis
Trade press·pharmatimes.com·Aug 13, 2026·Trial readout·High materiality
CompaniesKupandoAssetsKUP101Diseasesadvanced solid tumours